Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

Johnson & Johnson Reports 2014 Second-Quarter Results:

PR Newswire July 15, 2014

India Coronary Stent Market Would Continue to Grow in Double Digits and Abbott Vascular (NYSE:ABT) to Lead the Market

PR Newswire July 1, 2014

Cordis Corporation Launches SABER(TM) PTA Dilatation Catheter to Complement Portfolio of Peripheral Arterial Disease Treatments

Business Wire July 1, 2014

Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group

PR Newswire June 30, 2014

IPO Report: Minerva Neuroscience (NERV)

Equities.com June 25, 2014

CEO and Chairman of UPS, D. Scott Davis, Joins Johnson & Johnson Board of Directors

PR Newswire June 19, 2014

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

PR Newswire June 17, 2014

Medtronic Paying $43 Billion for Covidien, Moving HQ to Ireland

Equities.com June 16, 2014

Achillion (ACHN) Soars After FDA OKs Resumption of Trial for Hepatitis C Drug

Equities.com June 10, 2014

Catching Hepatitis: Why Merck (MRK) Was Willing to Break the Bank for Idenix (IDIX)

Equities.com June 9, 2014

Merck Beats Out AbbVie and JNJ, Agreeing to Pay $3.85 billion for Idenix

Equities.com June 9, 2014

DECN's Pharma Tech Subsidiary Places Significant Order for 50,000 Units of Genstrip 50 for Immediate Delivery to Select U.S. and International Distributors

Marketwired June 3, 2014

Decision Diagnostics Corp. Subsidiary Pharma Tech Enters International Markets With Conformité Européenne (CE) Mark Submission

Marketwired May 28, 2014

Nodality, Inc. Announces Publication of Promising Data in Melanoma in Journal of Translational Medicine

Business Wire May 28, 2014

Johnson & Johnson Medical Devices & Diagnostics Businesses Expanding Market Leadership with Innovative Products and Customer-Focused Solutions

PR Newswire May 22, 2014

Johnson & Johnson Announces Dividend Increase of 6.1%

PR Newswire April 24, 2014

Johnson & Johnson to Host Medical Devices & Diagnostics Business Review

PR Newswire April 23, 2014

OxySure Systems Picks Up Momentum Going Into 2014

Accesswire April 22, 2014

New Recycling Study Shows Lack Of Bins Is No. 1 Barrier To Recycling In The Home

PR Newswire April 17, 2014

VisionCare Appoints Industry Veterans, Mark Forchette, and John Ryan of ONSET Ventures to its Board of Directors

PR Newswire April 15, 2014